Breast Cancer Registry Platform
Recruiting now
Conditions studied: Breast Cancer
In brief
The purpose of the project is to set up a national, prospective, longitudinal, multicenter cohort study with associated satellites, a tumor registry platform, to document uniform data on characteristics, molecular diagnostics, treatment and course of disease, to collect patient-reported outcomes and to establish a decentralized biobank for patients with breast cancer in Germany.
Key facts
- Study ID
- NCT03417115
- Run by
- iOMEDICO AG
- People needed
- 6150
- Starts
- 2017-12-22
- Expected to finish
- 2032-06-01
- Last updated by the study team
- 2026-06-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Multiple sites all over germany — Many Locations, Germany (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.